与抗生素相关的发作:FAERS数据库的现实世界不成比例分析
Dan Zou1,2, Rui Zhang1, Lei Yu1
1Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Expert opinion on drug safety
|July 7, 2023
概括
这项研究分析了药物诱导的发作,发现10种抗生素与发作风险有关. 伊米-基拉斯在抗生素中显示出最高的风险,突出了需要仔细选择抗生素的必要性.
科学领域:
- 药物监督 药物监督 药物监督
- 临床神经学 临床神经学
- 药品安全 药品安全
背景情况:
- 药物诱导的发作是一个重要的临床问题,药物毒性约占初始发作的6%.
- 抗生素是已知的与药物相关的发作的原因,需要进一步调查特定药物风险.
- 现有的审查确定了一些具有发作风险的抗生素,但需要进行大规模分析才能进行全面的风险评估.
研究的目的:
- 评估各种可获得的抗生素与发作的发生之间的关联.
- 使用大型不良事件数据库,识别抗生素相关发作的潜在安全信号.
主要方法:
- 美国食品和药物管理局不良事件报告系统 (FAERS) 数据库的不成比例分析.
- 使用报告概率比率 (ROR) 和信息组件 (IC) 进行信号检测.
- 分析了使用韦布尔分布参数的发作时间.
主要成果:
- 对14407157份FAERS报告的分析确定了10种与发作显著相关的抗生素.
- 在41个首选术语中检测到10种抗生素的发作风险信号.
- 伊米佩内姆-基拉斯呈现出最高的发作报告几率比率 (ROR).
结论:
- 确定了10种抗生素与发作风险有显著关联.
- 在研究的抗生素中,imipenem-cilastatin与发作的相关性最高.
- 这些发现强调了在临床实践中考虑抗生素相关的发作风险的重要性.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
215
Seizures: Classification
436
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
436
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
350
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
350
Antiepileptic Drugs: Sodium Channel Blockers
686
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
686
Arteries of the Lower Limbs
217
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
217
Antiepileptic Drugs: GABAergic Pathway Potentiators
467
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
467


